Prevalencia del síndrome metabólico en consulta de medicina interna Hospital de San José de Bogotá DC. septiembre 2009 - marzo 2010

Prevalence of metabolic syndrome in patients attending the internal medicine outpatient clinic Hospital de San José, Bogotá DC. september 2009 - march 2010

El síndrome metabólico es un complejo de factores de riesgo predictores de enfermedad cardiovascular y diabetes. Objetivo: describir su prevalencia en pacientes de la consulta de medicina interna del Hospital de San José de Bogotá, teniendo en cuenta los criterios ATP 111, IDF 2005 e IDF-AHA/ NHLBI 2009. Métodos: estudio descriptivo de corte transversal de pacientes entre 30 y 70 años, excluyendo las gestantes, entre septiembre 2009 y marzo 2010. Resultados: se seleccionaron 315 pacientes, 30,5% hombres, con edad media de 52.4 (DE 9.6) años. La obesidad abdominal (81,2%) y el sedentarismo (68,2%) fueron los factores de riesgo más frecuentes. El 48,6% tenía hipertensión arterial, 45,1% cHDL bajo, 44,4% hipertrigliceridemia, 13,2% tabaquismo y 13% diabetes mellitus. La prevalencia entre hombres y mujeres fue mayor empleando los criterios diagnósticos IDF-AHA/NHLBI 2009: 56,2% (IC 95%:46.1-66.3) y 57,5% (IC 95% 51-64.1); y menor con ATP 111: 41,7% (IC 95% 31.6-51.7) y 45,6%.(IC 95%: 39-52.3). Fue más común el diagnóstico en mayores de 50 años. Conclusiones: la modificación de las definiciones del SM aumenta la prevalencia facilitando la detección temprana de factores de riesgo. Es mayor que la reportada por tratarse de población que asiste a control en un hospital de tercer nivel.

1. Alberti KG, Ecke!RH, Grundy SM, ZimmetPZ, Cleeman TI, Donato KA, et al. Hannonizing themetabolic syndrome:ajoint interim statement of theIntemational Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; IntemationalAtherosclerosis Society; and IntemationalAssociation for the Study of Obesity. Circulation 2009 Oct;%20; 120(16):1640-5.
2. Solymoss BC, Bourassa M G, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic riskprofileand coronary artery disease angiographic severity. Am J Cardiol. 2004 Jan 15; 93(2):159-64.
3. Müller Nordhom J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J. 2008; 29:1316-26.
4. World Health Organization (2008) 2008-2013 Action plan for the global strategy for the prevention and control of noncornmunicable diseases. WHO, Geneva.
5. Cameron AJ, Boyko EJ, Sicree RA, et al. Central obesity as a precursor to the metabolic syndrome in theAusDiab study and Mauritius. Obesity (Sil ver Spring) 2008; 16:2707-16.
6. Hoang KC, LeTV, Wong ND. The metabolic syndrome in East Asians. J Cardiometab Syndr. 2007; 2:276-82.
7. Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome inAsia. Asia Pac J Clin Nutr. 2008; l 7(suppl 1):37-42.
8. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. JAm Coll Cardiol. 2006; 47:1093-1100.
9. Harzallah F, Alberti H, Khalifa B. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. DiabetMed. 2006; 23:441-6.
10. Stolk R, Meijer R, Mali W, Grobbee D, GraafY. lTitrasound measurements of intraabdominal fat estímate the metabolic syndrome better than do measurements ofwaist circumference. Am J Clin Nutr. 2003; 77:857-60.
11. Kahn R, Buse J, Ferranini E, Stern M. Toe rnetabolic syndrome: time for a critica! appraisal. Diabetes Care. 2005; 28(9):2289-304.
12. Alberti KG, Zirnmet PZ. Definition, diagnosis and classification of diabetes mellitus and its comp]jcations. Part 1: diagnosis and classification of diabe­ tes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7):539-53.
13. Executive Surnmary ofTheThird Report ofThe NationalCholesterol Education Program (NCEP) Expert Panel on Detection, evaluation, AndTreatrnent of High Blood Cholesterol InAdults (AdultTreatrnent Panel III). JAMA 2001; 285(19):2486-97.
14. lnternational Diabetes Federation. Worldwide definition of Metabolic Syndrome. www.idf.org. 2005.
15. Grundy SM. Et al. Definition of metabolicsyndrome: Report of the National Heart, Lung, and Blood lnstitute/American HeartAssociation conference on scientific issues related to definition. Circulation 2004; 109(3):433-8.
16. Grundy SM, Hansen B, Smith SC, Jr., Cleeman n, Kahn RA. Clinical management of rnetabolic syndrome:reportof theAmericanHeartAssociation/ National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109(4):551-6.
17. Mule G, Nardi E, Cottone S, Cusirnano P, Volpe V, Piazza G, et al. Influence of metabolic syndrome on hypertension related target organ damage. J Intem Med. 2005; 257:503-13.
18. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. JHypertens. 2004; 22:1991-8.
19. Schillaci G, Pirro M, Pucci G, Mannarino MR, Gernelli F, Siepi D, et al. Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive rnen and women. Hypertension. 2006; 47:881-6.
20. Kawamoto R,TowtaH, OkaY, KodamaA. Metabolic syndrome amplifies the LDL cholesterol associated increases in carotid atherosclerosis. Intern Med. 2005; 44:1232-8.
21. InstitutoColombiano de Bienestar Familiar - ICBF. Encuesta Nacional de la Situación Nutricional en Colombia, 2005, primera edición. Bogotá: Pana­ mericana Formas e Impresos S.A. 2006; 83-4.
22. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: a recornmendation from the Centers for Disease Control andPrevention and the American College of Sports Medicine. JAMA 1995; 273:402.
23. Toe SeventhReport of the Joint NationalCornmittee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, lzzo JL, Janes DW et al;and the National High Blood Pressure Education Program Coordinating Cornmittee. JAMA. 2003; 289: 2560-72. Disponible en: http://jama.ama-assn.org/cgi/ reprint/289/
24. Aschner Chávez M IJSJTAPJ. Prevalence of the metabolic syndrome in a rural and urban population in Colombia. Diab Res Clin Prac. 2002;57:532.
25. Bernardo Lombo M, César Villalobos CTR, Claudia Satizábal M, Carlos A. Franco A. MD. Metabolic syndrome prevalence in patients attending the hypertension clinic at the Fundación Santa Fe de Bogotá. Revista Colombia­ na de Cardiología. 2006;12(6):472-8.
26. Villegas A, Botero J, Arango I, Arias S, Toro M. Prevalencia del síndrome metabólico en El Retiro, Colombia. lATREIA. 2003;16(4):291-7.
27. Rueda-Clausen C, Silva F, López-Jararnillo P. Epidemic of obesity and overweigh in Latín America and the Caribbean. Int J Cardiol. 2008; 123:11 l-2.
28. López-Jaramillo P, Rueda-Clausen C, Silva FA. The utility of different definitions of metabolic syndrome in Andean population. lnt J Cardiol. 2007;l l 6:421-2.
29. García RG, Cifuentes AE, Caballero RS, Sánchez L, López-Jararnillo P. A Proposal for an Appropriate Central Obesity Diagnosis in Latin American Population. lnt J Cardiol. 2005;110:263-4.
30. Pinzón JB, Serrano NC, Díaz LA, Mantilla G, Velasco HM, Martínez LX, et al. Impacto de las nuevas definiciones en laprevalencia de síndrome metabólico en una población de Bucaramanga, Colombia. Biomédica. 2007; 27:172-9.
31. Manzur F, Alvear C, Alayon A. Caracterización fenotípica y metabólica del síndrome metabólico en Cartagena de Indias. Rev Colomb Cardiol. 2008; 15:97-101.
32. Sánchez F, Jararnillo N, Vanegas A, Echeverría JG, León AC, Echeverría E, et al. Prevalencia y comportamiento de los factores de riesgo del síndrome metabólicosegún los diferentes intervalos de edad, en una población femeni­ na del área de influencia de la Clínica Las Américas, en Medellín, Colombia. Rev Colomb Cardiol. 2008;15:102-1O.
33. Merchán A. Síndrome metabólico y riesgo de enfermedad cardiovascular. Acta Med Coloma. 2005; 30:150-4.
34. Ervine RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009;13:1-8.
35. Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:236-7.
36. EsmaillzadehA, Mirrniran P, Azadbakht L, Etemadi A,Azizi F. 1-lighprevalence of the metabolic syndrome in lranian adolescents. Obesity. 200614:377-82.
37. Wagenknecht L, Langefeld C, Scherzinger A, Norris J, Haffner S, Saad M, et al. lnsulin sensitivity, insulin secretion, and abdominal fat: the lnsulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2003; 52:2490-6.
38. LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, Blair S Cardiorespiratory fitness is inversely associatedwiththe incidence of metabolic syndrome: a prospective study of men and women. Circulation. 2005; 112:505-12.
39. Pineda C. Síndrome metabólico: definición, historia, criterios. Colomb Med.2008;39: 96-106.
40. Katzmarzyk PT, León AS, Wilmore JH, Ski.nner JS, Rao DC, Rankinen T, et al. Targeting the metabolic syndrome witb exercise: evidence from HERlTAGE Family Study. Med Sci Sports Exerc. 2003; 35(10):1703-9.
41. Jakicic JM, Winters C, Lang W, Wing RR. Effects of intermittent exercise and use of home exercise equipment adherence, weight loss, and fitness in overweight women. JAMA. 1999; 282:1554-60.
42. Thomson PD, Buchner D, Pina IL, Balady GU, Williams MA, Marcus BH. Exercise and physical activity intheprevention and treatment of atherosclerotic cardiovascular disease: a statement from the American Heart Association Council on Clinical Cardiology (Subcommittee of exercise, Rehabilitation and Prevention) and the Council on Nutrition, Physical Activity and Metabolism. Circulation. 2003;107:3109-16.
43. Halbert JA, Silagy CA, Finucane P, Withers RT, HamdorfPA,Andrews GR. The effectiveness of exercise training in lowering blood pressure: a meta­ analysis of randomisedcomroUedtrials of 4 weeks or longer.J Hum Hypertens. 1997;11:641-9.
44. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levelsofHDL cholesterol and highlevels of LDL cholesterol. N Engl J Med. 1998;339: 12-20.
45. López Jaramillo P, Pradilla L, Castillo V, Lahera V. Socioeconomic pathology as a cause of regional differences in the prevalence of metabolic syndrome and pregnancy induce hypertension. Rev Esp Cardiol. 2007; 60(2):168-78.
46. Asociación Colombiana de Endocrinología. ConsensoColombiano de Sín­ drome Metabólico. Bogotá;2006;26.
47. Martínez C, Franch J, Romero J. Prevalence of metabolic sy.ndrome in the adult population of Yecla (Murcia): Degree of agreement between three definitions.AtenciónPrimaria. 2006;38(2):72-8l.